MarketScreener Homepage > News > Sectors > Healthcare

News : Sectors

NOVARTIS

Recruits new compliance head from Siemens after ethics stumbles

MERCK AND COMPANY

Roundup cancer verdict sends Bayer shares sliding

BAYER

Monsanto ordered to pay $289 million in world's first Roundup cancer trial

11:28a	MEDTRONIC : Launches Patient Engagement Program That Leverages Gamification to Help Motivate and Engage Patients Living with Diabetes	AQ
11:26a	JOHNSON & JOHNSON : Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX Split Dosing Regimen	AQ
11:26a	JOHNSON & JOHNSON : Announces Chris DelOrefice as Vice President of Investor Relations	AQ
11:25a	INTELGENX TECHNOLOGIES : Reports Second Quarter 2018 Financial Results	AQ
11:11a	SIHUAN PHARMACEUTICAL : Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China	PU
11:06a	GERRESHEIMER AT MEDTEC CHINA : order processing, industrial-scale production, and contract manufacturing from a single source	PU
10:51a	INTEGRATED DIAGNOSTICS : Launch of radiology business in Egyptian market	PU
10:08a	STEMLINE THERAPEUTICS : Priority Review for Stemline's blood cancer therapy	AQ
10:08a	BIOGEN : NICE draft guidance recommends against Spinraza for SMA	AQ
10:07a	BIOCENTURY - MANAGEMENT TRACKS : FDA, Allergan	AQ
10:06a	REGENERON PHARMACEUTICALS : FDA issues CRL for 12-week Eylea regimen	AQ
10:01a	ABCAM : Block listing Interim Review	PU
09:05a	BIOTEST AG : Biotest increases revenues to EUR 200.7 million in the first half of 2018	EQ
09:04a	AZURRX BIOPHARMA, INC. (NASDAQ : AZRX) Files An 8-K Regulation FD Disclosure	AQ
09:01a	CATALENT : Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.	BU

Find Out How MarketScreener Premium Can Help You.
The best opportunities. On all the markets. In a single subscription.

12:10p	AMPIO PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
12:10p	ARTEMIS THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
12:01p	WELLCARE HEALTH PLANS : Announces Closing of $750 Million of Senior Notes	PR
12:01p	SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results	GL
11:56a	ILLUMINA : Notice of Intent to Sole Source Illumina brand NextSeq	AQ
11:49a	XOMA : Reports Second Quarter 2018 Financial Results	AQ
11:49a	MIRAGEN THERAPEUTICS : Reports Second Quarter 2018 Financial Results and Provides Corporate Update	AQ
11:49a	VERTEX PHARMACEUTICALS : VRTX - FDA Approves ORKAMBI as First Medicine to Treat the Underlying Cause of Cystic Fibrosis for Children Ages 2-5 Years with Most Common Form of the Disease	AQ
11:49a	MYOKARDIA : to Present at the 2018 Wedbush Pacgrow Healthcare Conference	AQ
11:49a	MORPHOSYS : and I-Mab Biopharma Announce China IND Submission of TJ202/MOR202	AQ
11:49a	PACIRA PHARMACEUTICALS : to Present at the 2018 Wedbush Pacgrow Healthcare Conference	AQ
11:49a	GENMAB : Announces Financial Results for the First Half of 2018	AQ
11:49a	ACELRX PHARMACEUTICALS : Announces Full Exercise of Underwriters' Option to Purchase Additional Shares	AQ
11:49a	HALOZYME THERAPEUTICS : Reports Second Quarter 2018 Results	AQ
11:48a	ANI PHARMACEUTICALS : Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance	AQ
11:48a	CORBUS PHARMACEUTICALS : Reports 2018 Second Quarter Financial Results and Provides Business Update	AQ
11:48a	SUNESIS PHARMACEUTICALS : Reports Second Quarter 2018 Financial Results and Recent Highlights	AQ
11:48a	CATABASIS PHARMACEUTICALS : to Present at 2018 Wedbush PacGrow Healthcare Conference	AQ
11:48a	GENMAB : Announces Submission of U.S. & EU Regulatory Applications Seeking Approval of DARZALEX Split Dosing Regimen	AQ
11:48a	ABATTIS BIOCEUTICALS : Announces share buy back program	AQ
11:48a	SYNDAX PHARMACEUTICALS : Reports Second Quarter 2018 Financial Results and Provides Clinical and Business Update	AQ
11:48a	KERYX BIOPHARMACEUTICALS : Announces Second Quarter 2018 Financial Results	AQ
11:48a	SYNERGY PHARMACEUTICALS : Reports Second Quarter 2018 Financial Results and Business Update	AQ
11:48a	NEOS THERAPEUTICS : Reports Second Quarter 2018 Financial Results	AQ
11:48a	SUPERNUS PHARMACEUTICALS : Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue	AQ
11:48a	RA PHARMACEUTICALS : Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 Program	AQ
11:48a	MOTIF BIO : Announces Notice of Allowance for Two U.S. Iclaprim Patents with Expiration in 2037	AQ
11:48a	KURA ONCOLOGY : to Present at 2018 Wedbush PacGrow Healthcare Conference	AQ
11:48a	ALBIREO PHARMA : to Present at Wedbush PacGrow Healthcare Conference	AQ
11:48a	ALLERGAN : Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process	AQ
11:48a	Depomed Announces Second-Quarter 2018 Financial Results	AQ
11:48a	JOHNSON & JOHNSON : to Participate in the 2018 Wells Fargo 13th Annual Healthcare Conference	AQ
11:48a	CONCORDIA INTERNATIONAL CORP. : Announces Second Quarter 2018 Results	AQ
11:48a	CATALYST PHARMACEUTICALS : Announces Second Quarter 2018 Financial Results and Provides Corporate Update	AQ
11:48a	CHIMERIX : Announces Second Quarter 2018 Financial Results	AQ
11:48a	ELITE PHARMACEUTICALS : Glenmark Pharmaceuticals' partner Elite Pharmaceuticals receives US FDA approval for generic methadone hydrochloride tablets	AQ
11:48a	CARA THERAPEUTICS : Reports Second Quarter 2018 Financial Results	AQ
11:48a	MACROGENICS : Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results	AQ
11:48a	AQUINOX PHARMACEUTICALS : Announces Second Quarter 2018 Financial Results	AQ
11:48a	ARROWHEAD PHARMACEUTICALS : Reports Fiscal 2018 Third Quarter Results	AQ
11:48a	FATE THERAPEUTICS : to Present at the 2018 Wedbush PacGrow Healthcare Conference	AQ
11:48a	GW PHARMACEUTICALS : Reports Fiscal Third Quarter 2018 Financial Results and Operational Progress	AQ
11:48a	CALITHERA BIOSCIENCES : Reports Second Quarter 2018 Financial Results and Recent Highlights	AQ
11:47a	JOHNSON & JOHNSON : to Participate in Barclays Global Consumer Staples Conference	AQ
11:47a	GLENMARK PHARMACEUTICALS : Announces FDA Acceptance of the Company's First New Drug Application for Ryaltris for Patients with Seasonal Allergic Rhinitis	AQ
11:47a	TG THERAPEUTICS : Provides Business Update and Reports Second Quarter 2018 Financial Results	AQ
11:47a	PROGENICS PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock	AQ
11:46a	ROYAL PHILIPS : Philips and Targos collaborate to advance digital pathology education and enhance global training	PU
11:45a	BTG : receives not-approvable letter from the US FDA for ELEVAIR	AQ
11:28a	MEDTRONIC : Begins Pilot Study of Investigational Extravascular ICD System	AQ

The best opportunities.
All the markets. Each month. In one click.

Discover

12:27p	PHIBRO ANIMAL HEALTH CORPORATION : to Participate in the Morgan Stanley Annual Global Healthcare Conference	AQ
12:26p	FIBROGEN : FGEN) Shares Bought by Russell Investments Group Ltd.	AQ
12:26p	CYTODYN : Appoints Michael A. Klump to Board of Directors	AQ
12:25p	Agile Therapeutics Inc (AGRX) Holdings Cut by Russell Investments Group Ltd.	AQ
12:20p	REFLECT SCIENTIFIC : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ

1 2 3 4 5 6 7 8 9 10 Next

MOST READ NEWS

1	Musk says Silver Lake, Goldman advising on taking Tesla private
2	HANG SENG : Tencent games revenue in focus after China blocks 'Monster Hunter - World'
3	TESLA : TESLA : MUSK'S MISSIVE Tesla boss says Saudis want to support buyback
4	ADMIRAL GROUP : Bain Capital to take UK insurer esure private in £1.21 billion deal
5	OROCOBRE LIMITED : OROCOBRE : Advantage Lithium Release Study on Cauchari JV ORE ASX Release_Advantage Lithium..